Author | Jason Luke, MD | OncLive

Author | Jason Luke, MD

Articles

Dr. Luke on the Clinical Trial Landscape for Melanoma

November 29, 2017

Jason Luke, MD, assistant professor of medicine at the University of Chicago Medicine, discusses the clinical trial landscape for melanoma

Dr. Luke on the Future Role of Immunotherapy Combinations in Melanoma

November 10, 2017

Jason Luke, MD, assistant professor of medicine at the University of Chicago Medicine, discusses the future of immunotherapy combinations for patients with melanoma.

Dr. Luke on the Combination of Pembrolizumab and T-VEC for Melanoma

October 28, 2017

Jason Luke, MD, assistant professor of medicine at the University of Chicago Medicine, discusses the combination of pembrolizumab (Keytruda) and talimogene laherparepvec (T-VEC; Imlygic) for the treatment of patients with melanoma.

Dr. Luke Discusses PD-1 Plus IDO Inhibitors in Melanoma

October 19, 2017

Jason Luke, MD, assistant professor of medicine, University of Chicago Medicine, discusses the combination approach of a PD-1 antibody plus an IDO inhibitor for patients with melanoma.

x